Home » Supporting Your Practice » Medicine (page 2)

Medicine

Dental Implant Survival and Complication Rate for Patients with Diabetes Mellitus

We may be in the early stages of a good news story. My interview with Dr. Thomas Oates, Professor and Chair of the Department of Advanced Oral Sciences and Therapeutics at the University of Maryland, was about a recent study he co-authored and published in Clinical Implant Dentistry & Related Research journal, titled: Dental Implant Survival and Complication Rate over 2 Years for Individuals with Poorly Controlled Type 2 Diabetes Mellitus. The study offers hope that diabetic patients could benefit from successful implant treatment without complications. I hope you enjoy the interview!  Chiraz Guessaier, CDA Oasis Manager Highlights Background Emerging evidence ...

Read More »

Oral Cancer Complications: Dysgeusia

Drs. Debbie Saunders and Joel Epstein return to continue their series of presentations on oral cancer. Today they speak about one oral cancer complication: Dysgeusia.  Highlights Dysgeusia is another common oral complication which presents during cancer treatment. Dysgeusia is defined as an abnormal or impaired sense of taste, an unpleasant alteration of taste sensation or a distortion or perversion of the sense of taste. Taste is complex, with 5 tastes noted: sour, salt, sweet, bitter and umami.  In addition “spicy” taste is mediated by c-fibers and fat may be appreciated by specific receptors and by texture.  Taste along with texture, ...

Read More »

Hypophosphatasia: Advocating for the Patient

In the last of four segments dedicated to hypophosphatasia (HPP), Debbie Taillefer, President and Founder, Soft Bones Canada, speaks to Dr. Suham Alexander about the importance of creating a community and patient advocacy forum for patients afflicted with soft bone diseases. Highlights Soft Bones Canada was created to fill the void that Debbie and other patients required when they were newly diagnosed with HPP. Soft Bones Canada works to help support and educate patients as well as to bridge the gap with medical professionals. Dentists can play an important role in early diagnosis of the disease since the earliest signs ...

Read More »

Hypophosphatasia: A General Dentist’s Experience

Dr. Suham Alexander speaks to Dr. Bob Schroth in this third segment about hypophosphatasia (HPP) and the dental implications and management of patients with this condition. Children with HPP have some definite dental challenges. The developing teeth in these children lack cementum on the roots which leads to premature exfoliation. Additionally, large pulp chambers and irregular dentin and enamel defects increase the extent and risk of caries development. Radiographic tell-tale signs in HPP include: enlarged pulp horns, lower bone height interproximally as well as bony defects. Prudent use of dental radiographs is recommended in these patients as determined on a ...

Read More »

The Genetic Foundation of Hypophosphatasia

Dr. Cheryl Greenberg, a pediatrician and geneticist, speaks to Dr. Suham Alexander about the clinical history and manifestations of HPP in her unique patient population in Winnipeg, MB. HPP is over-represented in the Mennonite population in Manitoba due to a “founder” mutation. Highlights HPP is categorized by age of onset: perinatal, infant, juvenile, adult (systemic forms) and odonto-hypophosphatasia (dental form). All patients with HPP must have a low level of alkaline phosphatase. There is a strong genetic basis for the various forms of HPP. There are more than 300 mutations described in the literature. However, one gene is responsible for ...

Read More »

Drug Therapy During Pregnancy with Dr. Aviv Ouanounou

Dr. Aviv Ouanounou returns to Oasis Discussions to speak about drug therapy during pregnancy. This presentation is based on an article authored by Drs. Aviv Ouanounou and Dan Haas, from the University of Toronto, in the British Dental Journal in 2016. The article was also selected by the Royal College of Dental Surgeons of Ontario as a Practice Enhancement and Knowledge (PEAK*) resource for Ontario dentists. *The goal of PEAK is to provide Ontario dentists with key articles on a wide-range of clinical and non-clinical topics from dental literature around the world. Highlights Pregnancy is a special time in a ...

Read More »

What is Hypophosphatasia (HPP)?

Highlights In the first segment of a 4-part series, Dr. Marc McKee introduces Oasis Discussions followers to a soft bone disease which also has a significant dental impact. Hypophosphatasia (HPP) is a very rare disease that has a prevalence of  approximately 1:100,000 live births.  Much progress has been made in recent years in understanding HPP, and in treating patients with this condition. HPP is a disease which negatively affects mineralization due to an increase in inhibitory pyrophosphate levels caused by decreased activity of an enzyme called tissue non-specific alkaline phosphatase (TNAP, TNSALP). This results in the inhibition of mineralization causing ...

Read More »

COHN Webinar: Medication-Related Osteonecrosis of the Jaw (MRONJ): An Update for the Dental Practitioner

The webinar is hosted by Dr. Tanya Gibson. The webinar explores the pathogenesis and risk factors of medication-related osteonecrosis of the jaw. As well, it looks at the recommended management strategies based on the clinical stage at the time of presentation. Participants will learn: the pathogenesis of MRONJ. risk factors for developing MRONJ. the clinical staging of MRONJ. management strategies for MRONJ. To register and attend the webinar, you can find more information here   Dr. Tanya Gibson DDS Tanya Marie Gibson, DDS, a native of Cleveland, Ohio, is an assistant professor at the University of Missouri Kansas City (UMKC) ...

Read More »